Reducing Timelines and Eliminating the White Space in Complex Biologic & Bioconjugate Development
Published: | Updated:
Sponsored
Campbell Bunce, CSO, Abzena, explains their integrated drug development model that combines front-end R&D with process development and manufacturing under one roof.